SESSION TITLE: Fellow Case Report Poster - Lung Pathology
SESSION TYPE: Affiliate Case Report Poster
PRESENTED ON: Tuesday, October 25, 2016 at 01:30 PM - 02:30 PM
INTRODUCTION: Ibrutinib is an oral Bruton tyrosine kinase (BTK) inhibitor used in the treatment of B-cell lymphomas, including relapsed or refractory chronic lymphocytic leukemia. We report a case of a patient who developed organizing pneumonia after treatment with Ibrutinib.